Joong Hyun Park

Dr. Joong Hyun Park

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Stroke
Verified
Journal Article
Closed access
PDF file
JYJoonsang Yoo
Joonsang Yoo
YKYoung Dae Kim
Young Dae Kim
HPHyungjong Park
Hyungjong Park
BKByung Moon Kim
Byung Moon Kim
OBOh Young Bang
Oh Young Bang
OIon behalf of the SECRET Study Investigators
on behalf of the SECRET Study Investigators
Background and Purpose: Patients with acute stroke are often accompanied by comorbidities, such as active cancer. However, adequate treatment guidelines are not available for these patients. The purpose of this study was to evaluate the association between cancer and the outcomes of reperfusion therapy in patients with stroke. Methods: We compared treatment outcomes in patients who underwent reperfusion therapy, using a nationwide reperfusion therapy registry. We divided the patients into 3 groups according to cancer activity: active cancer, nonactive cancer, and without a history of cancer. We investigated reperfusion processes, 24-hour neurological improvement, adverse events, 3-month functional outcome, and 6-month survival and related factors after reperfusion therapy. Results: Among 1338 patients who underwent reperfusion therapy, 62 patients (4.6%) had active cancer, 78 patients (5.8%) had nonactive cancer, and 1198 patients (89.5%) had no history of cancer. Of the enrolled patients, 969 patients received intravenous thrombolysis and 685 patients underwent endovascular treatment (316 patients received combined therapy). Patients with active cancer had more comorbidities and experienced more severe strokes; however, they showed similar 24-hour neurological improvement and adverse events, including cerebral hemorrhage, compared with the other groups. Although the functional outcome at 3 months was poorer than the other groups, 36.4% of patients with active cancer showed functional independence. Additionally, 52.9% of the patients with determined stroke etiology showed functional independence despite active cancer. During the 6-month follow-up, 46.6% of patients with active cancer died, and active cancer was independently associated with poor survival (hazard ratio, 3.973 [95% CI, 2.528–6.245]). Conclusions: In patients with active cancer, reperfusion therapy showed similar adverse events and short-term outcomes to that of other groups. While long-term prognosis was worse in the active cancer group than the nonactive cancer groups, not negligible number of patients had good functional outcomes, especially those with determined stroke mechanisms.

1 December 2022 in Stroke
Verified
Journal Article
Closed access
PDF file
HPHyungjong Park
Hyungjong Park
YKYoung Dae Kim
Young Dae Kim
HYO SUK NAMHYO SUK NAM
HYO SUK NAM
JYJoonsang Yoo
Joonsang Yoo
SSSung-Il Sohn
Sung-Il Sohn
OIon behalf of the SECRET Study Investigators
on behalf of the SECRET Study Investigators
Background: A high and low estimated glomerular filtration rate (eGFR) could affect outcomes after reperfusion therapy for ischemic stroke. This study aimed to determine whether renal function based on eGFR affects mortality risk in patients with ischemic stroke within 6 months following reperfusion therapy. Methods: This prospective registry–based cohort study included 2266 patients who received reperfusion therapy between January 2000 and September 2019 and were registered in the SECRET (Selection Criteria in Endovascular Thrombectomy and Thrombolytic Therapy) study or the Yonsei Stroke Cohort. A high and low eGFR were based on the Chronic Kidney Disease Epidemiology Collaboration equation and defined, respectively, as the 5th and 95th percentiles of age- and sex-specific eGFR. Occurrence of death within 6 months was compared among the groups according to their eGFR such as low, normal, or high eGFR. Results: Of the 2266 patients, 2051 (90.5%) had a normal eGFR, 110 (4.9%) a low eGFR, and 105 (4.6%) a high eGFR. Patients with high eGFR were younger or less likely to have hypertension, diabetes, or atrial fibrillation than the other groups. Active cancer was more prevalent in the high-eGFR group. During the 6-month follow-up, there were 24 deaths (22.9%) in the high-eGFR group, 37 (33.6%) in the low-eGFR group, and 237 (11.6%) in the normal-eGFR group. After adjusting for variables with P <0.10 in the univariable analysis, 6-month mortality was independently associated with high eGFR (hazard ratio, 2.22 [95% CI, 1.36–3.62]; P =0.001) and low eGFR (HR, 2.29 [95% CI, 1.41–3.72]; P =0.001). These associations persisted regardless of treatment modality or various baseline characteristics. Conclusions: High eGFR as well as low eGFR were independently associated with 6-month mortality after reperfusion therapy. Kidney function could be considered a prognostic factor in patients with ischemic stroke after reperfusion therapy.

7 September 2023 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
JYJin-Sung Yuk
Jin-Sung Yuk
JLJin San Lee
Jin San Lee
JPJoong Hyun Park
Joong Hyun Park
Introduction: Menopausal hormone therapy (MHT) is used to alleviate the symptoms associated with menopause, despite the lack of recommendations for MHT in preventing dementia. Recent nationwide studies have explored the association between MHT and dementia risk, but the findings remain limited. This study aims to investigate the association between MHT and the incidence of Alzheimer’s disease (AD) and non-AD dementia using national population data from Korea.Methods: We conducted a retrospective study using data from the National Health Insurance Service in Korea between January 1, 2002, and December 31, 2019. Women over 40 years were eligible for this study and classified into the MHT or non-MHT groups. The MHT group consisted of women who used Tibolone (TIB), combined estrogen plus progestin by the manufacturer (CEPM), estrogen, combined estrogen plus progestin by a physician (CEPP), and transdermal estrogen during menopause. We compared the risk of dementia between the MHT and non-MHT groups.Results: The study included 1,399,256 patients, of whom 387,477 were in the MHT group, and 1,011,779 were in the non-MHT group. The median duration of MHT was 23 months (range: 10–55 months). After adjusting for available confounders, we found that different types of MHT had varying effects on the occurrence of dementia. TIB (HR 1.041, 95% confidence interval (CI) 1.01–1.072) and oral estrogen alone (HR 1.081, 95% CI 1.03–1.134) were associated with a higher risk of AD dementia. In contrast, there was no difference in the risk of AD dementia by CEPM (HR 0.975, 95% CI 0.93–1.019), CEPP (HR 1.131, 95% CI 0.997–1.283), and transdermal estrogen (HR 0.989, 95% CI 0.757–1.292) use. The use of TIB, CEPM, and oral estrogen alone increased the risk of non-AD dementia (HR 1.335, 95% CI 1.303–1.368; HR 1.25, 95% CI 1.21–1.292; and HR 1.128, 95% CI 1.079–1.179; respectively), but there was no risk of non-AD dementia in the other MHT groups (CEPP and topical estrogen).Conclusion: Our findings indicate that MHT has varying effects on the incidence of AD and non-AD dementia. Specifically, TIB, CEPM, and oral estrogen alone increase the risk of non-AD dementia, while transdermal estrogen is not associated with dementia risk. It is essential to consider the type of MHT used when assessing the risk of dementia in women.

Verified
Journal Article
Open access
PDF file
YKYoung Dae Kim
Young Dae Kim
JHJi Hoe Heo
Ji Hoe Heo
JYJoonsang Yoo
Joonsang Yoo
HPHyungjong Park
Hyungjong Park
BKByung Moon Kim
Byung Moon Kim
HYO SUK NAMHYO SUK NAM
HYO SUK NAM
We investigated whether there was an annual change in outcomes in patients who received the thrombolytic therapy or endovascular treatment (EVT) in Korea. This analysis was performed using data from a nationwide multicenter registry for exploring the selection criteria of patients who would benefit from reperfusion therapies in Korea. We compared the annual changes in the modified Rankin scale (mRS) at discharge and after 90 days and the achievement of successful recanalization from 2012 to 2017. We also investigated the determinants of favorable functional outcomes. Among 1230 included patients, the improvement of functional outcome at discharge after reperfusion therapy was noted as the calendar year increased (p < 0.001). The proportion of patients who were discharged to home significantly increased (from 45.6% in 2012 to 58.5% in 2017) (p < 0.001). The successful recanalization rate increased over time from 78.6% in 2012 to 85.1% in 2017 (p = 0.006). Time from door to initiation of reperfusion therapy decreased over the years (p < 0.05). These secular trends of improvements were also observed in 1203 patients with available mRS data at 90 days (p < 0.05). Functional outcome was associated with the calendar year, age, initial stroke severity, diabetes, preadmission disability, intervals from door to reperfusion therapy, and achievement of successful recanalization. This study demonstrated the secular trends of improvement in functional outcome and successful recanalization rate in patients who received reperfusion therapy in Korea.

31 December 2019 in Journal of Neurosonology and Neuroimaging
Verified
Journal Article
Open access
PDF file
JHJi Eun Han
Ji Eun Han
TKTaemin Kim
Taemin Kim
JPJoong Hyun Park
Joong Hyun Park
JBJong Sam Baik
Jong Sam Baik
JKJeong Yeon Kim
Jeong Yeon Kim
HYHyun-Jeung Yu
Hyun-Jeung Yu
Background: Though blood viscosity (BV) is the major factor influencing pulsatility index (PI), it is unknown whether PI is related with BV in acute ischemic stroke. We explored the association between transcranial Doppler (TCD) PI and BV in acute ischemic stroke patient. Methods: Between January 2018 and December 2018, patients aged 40 years or older with an ischemic stroke or transient ischemic attack within 24 hours of symptom onset were recruited for the study. The scanning capillary-tube viscometer was used to assess whole blood viscosity. Doppler signals showing the highest mean flow velocity were used for PI calculation. Results: A total of 125 patients were enrolled for the study. The most frequent stroke subtype was lacunar stroke (42%), followed by stroke of undetermined etiology negative work-up (29%), and large artery atherosclerosis (19%). The mean middle cerebral artery (mMCA) PI was significantly associated with BV. Age, diabetes and BV were associated with mMCA PI, suggesting that increased mMCA PI is associated with old age, presence of diabetes, and increased BV. Conclusion: Pulsatility of MCA is highly associated with BV in acute ischemic stroke patient within 24 hours of symptom onset. Our findings indicate that TCD PI may be a useful non-invasive imaging modality for exploring the viscosity of cerebral vessels, which in turn is related to systemic BV.

1 January 2021 in Korean Circulation Journal
Verified
Journal Article
Open access
PDF file
OLOh-Hyun Lee
Oh-Hyun Lee
YKYoung Dae Kim
Young Dae Kim
Jung Sun KimJung Sun Kim
Jung Sun Kim
NSNak-Hoon Son
Nak-Hoon Son
HPHui-Nam Pak
Hui-Nam Pak
JPJai-Wun Park
Jai-Wun Park
Korean Circulation Journal 대한심장학회지 순환기 Lee OH, et al. Korean Circ J. 2021 Jul;51(7):626-638. https://doi.org/10.4070/kcj.2020.0527